Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Tuvalu
Tuvalu: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 1.1% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Tuvalu, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Tuvalu is 1.1%, measured in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 8.3% on the previous year and down 15.4% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Tuvalu peaked at 1.3% in 2015 and was at its lowest, 1.1%, in 2024.
That places Tuvalu 26th out of 215 countries with data for 2024, putting it in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Tuvalu, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.3% | — |
| 2016 | 1.2% | -7.7% |
| 2017 | 1.3% | +8.3% |
| 2018 | 1.3% | +0.0% |
| 2019 | 1.3% | +0.0% |
| 2020 | 1.2% | -7.7% |
| 2021 | 1.2% | +0.0% |
| 2022 | 1.2% | +0.0% |
| 2023 | 1.2% | +0.0% |
| 2024 | 1.1% | -8.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.3% | 1.2% | 1.3% | 5 |
| 2020s | 1.2% | 1.1% | 1.2% | 5 |
Countries ranked near Tuvalu
More development goals data for Tuvalu
- Red List Index 0.8339 (2025)
- Number of refugees per 100,000 population, by country of origin 0 (2025)
- Manufacturing value added per capita 79.36 (2025)
- Number of transboundary breeds 5 (2025)
- Number of transboundary breeds (not extinct) 5 (2025)
- Number of transboundary breeds with unknown risk status 5 (2025)
- Number of local breeds with unknown risk status 3 (2025)
- Number of local breeds (not extinct) 3 (2025)
- Number of local breeds kept in the country 3 (2025)
- Infant deaths 4 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Tuvalu?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Tuvalu was 1.1% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Tuvalu?
- The highest recorded value was 1.3% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Tuvalu?
- The lowest recorded value was 1.1% in 2024.
- How does Tuvalu rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Tuvalu ranks 26th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Tuvalu?
- Over the last ten years it is down 15.4%. The long-run trend across the full record is falling.
- Where does this Tuvalu data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).